×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ROIV – roivant sciences ltd. - common shares (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ROIV
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/16
11:08 am
roiv
Roivant Sciences (ROIV) was given a new $40.00 price target by Piper Sandler.
Low
Report
Roivant Sciences (ROIV) was given a new $40.00 price target by Piper Sandler.
4/15
02:43 pm
roiv
Roivant Sciences (ROIV): A Clinical Trial Win Meets a Phase 3 Failure [Yahoo! Finance]
Low
Report
Roivant Sciences (ROIV): A Clinical Trial Win Meets a Phase 3 Failure [Yahoo! Finance]
4/9
07:28 am
roiv
Ohio governor: Vivek Ramaswamy faces little-known GOP challengers [USA TODAY]
Low
Report
Ohio governor: Vivek Ramaswamy faces little-known GOP challengers [USA TODAY]
4/3
07:41 am
roiv
Should Brepocitinib's New Trials and Batoclimab's Setback Require Action From Roivant Sciences (ROIV) Investors? [Yahoo! Finance]
Medium
Report
Should Brepocitinib's New Trials and Batoclimab's Setback Require Action From Roivant Sciences (ROIV) Investors? [Yahoo! Finance]
4/2
04:38 pm
roiv
Roivant Sciences Ltd. (ROIV) Discusses Brepocitinib Program Expansion and Phase III Batoclimab Data Update Transcript [Seeking Alpha]
Low
Report
Roivant Sciences Ltd. (ROIV) Discusses Brepocitinib Program Expansion and Phase III Batoclimab Data Update Transcript [Seeking Alpha]
4/2
04:38 pm
roiv
Immunovant, Inc. (IMVT) Discusses Brepocitinib Program Expansion and Batoclimab Phase III Data Update Transcript [Seeking Alpha]
Low
Report
Immunovant, Inc. (IMVT) Discusses Brepocitinib Program Expansion and Batoclimab Phase III Data Update Transcript [Seeking Alpha]
4/2
10:29 am
roiv
Roivant Sciences Adds Brepocitinib LPP Trial as Batoclimab Misses Phase III TED Endpoint [Yahoo! Finance]
Low
Report
Roivant Sciences Adds Brepocitinib LPP Trial as Batoclimab Misses Phase III TED Endpoint [Yahoo! Finance]
4/2
06:52 am
roiv
Immunovant falls on late-stage trial setback for TED therapy [Seeking Alpha]
Medium
Report
Immunovant falls on late-stage trial setback for TED therapy [Seeking Alpha]
Date
Time
Symbol
Company Name
Action
%Chg
2/6/2026
07:00 am
roiv
roivant sciences ltd. - common shares
IN-LINE
Report
12.4%
roivant sciences ltd. - common shares
11/10/2025
07:00 am
roiv
roivant sciences ltd. - common shares
BEAT
Report
0.9%
roivant sciences ltd. - common shares
8/11/2025
07:00 am
roiv
roivant sciences ltd. - common shares
MISS
Report
-3.1%
roivant sciences ltd. - common shares
5/29/2025
07:00 am
roiv
roivant sciences ltd. - common shares
MISS
Report
5.6%
roivant sciences ltd. - common shares
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
4/16
05:24 pm
roiv
Form 144/A Roivant Sciences Ltd. Filed by: Gline Matthew
Low
Report
Form 144/A Roivant Sciences Ltd. Filed by: Gline Matthew
4/16
04:34 pm
roiv
Form 144 Roivant Sciences Ltd. Filed by: Gline Matthew
Low
Report
Form 144 Roivant Sciences Ltd. Filed by: Gline Matthew
4/10
06:00 pm
roiv
Form 4 Roivant Sciences Ltd. For: Apr 08 Filed by: Humes Jennifer
Low
Report
Form 4 Roivant Sciences Ltd. For: Apr 08 Filed by: Humes Jennifer
4/8
04:08 pm
roiv
Form 144 Roivant Sciences Ltd. Filed by: Humes Jennifer
Low
Report
Form 144 Roivant Sciences Ltd. Filed by: Humes Jennifer
4/2
07:15 pm
roiv
Form 4 Roivant Sciences Ltd. For: Mar 31 Filed by: Torti Frank
Low
Report
Form 4 Roivant Sciences Ltd. For: Mar 31 Filed by: Torti Frank
4/2
07:00 am
roiv
Form 8-K Roivant Sciences Ltd. For: Apr 02
Medium
Report
Form 8-K Roivant Sciences Ltd. For: Apr 02
4/1
07:21 pm
roiv
Form 4 Roivant Sciences Ltd. For: Mar 30 Filed by: Gline Matthew
Medium
Report
Form 4 Roivant Sciences Ltd. For: Mar 30 Filed by: Gline Matthew
4/1
07:19 pm
roiv
Form 4 Roivant Sciences Ltd. For: Mar 30 Filed by: Sukhatme Mayukh
Medium
Report
Form 4 Roivant Sciences Ltd. For: Mar 30 Filed by: Sukhatme Mayukh
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: